RNS Number : 7474E

Eco Animal Health Group PLC

15 March 2022

ECO Animal Health Group plc

("ECO" or "the ECO Group") (AIM: EAH)

Pre-close Trading update

ECO Animal Health Group plc, a leader in the development, registration and marketing of pharmaceutical products for global animal health markets provides an unaudited trading update for the financial year ending 31 March 2022.

ECO commented in early January 2022 that China pork prices were volatile, and producers remained cautious. Although these trading conditions have persisted throughout the first quarter of 2022, ECO has continued to trade in line with revised revenue and margin expectations.

Further encouraging progress has been made within the R&D portfolio and investment was maintained at the budgeted rate, resulting in R&D cash expenditure, including capitalisation, of about 13% of revenue in the full year and a charge to the income statement of GBP8.7million. This charge to the income statement reflects some exciting early-stage technologies. This, together with further investment in critical support functions, is expected to result in EBITDA (for the year ending 31 March 2022) 15% to 20% below consensus expectations.

Exposure to Russia and Ukraine

The ECO Group has no business in Ukraine. The annual revenue derived from Russia has been less than GBP0.5m in each of the last three financial years. The current receivables due from the ECO distributor in Russia are approximately EUR430,000 and the Board continues to explore a number of mechanisms to recover this debt.

Marc Loomes, CEO said:

"The pork commodity price in China continues to be volatile but we are pleased with recent trading and our expectation of meeting revenue consensus is an important indicator of a return to more stable trading conditions. We have kept investment on critical organisation development and strategic R&D at our planned levels despite the reduced revenues from China. This decision is beginning to bear fruit and we look forward with excitement to the announcement of new regulatory approvals."

"We hope for a speedy resolution to the conflict in Ukraine and stay ready to support our business partners in Eastern Europe in any way we can."

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR") as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.


   ECO Animal Health Group plc 
   Marc Loomes (CEO) 
   Chris Wilks (FD)                            020 8447 8899 
 IFC Advisory 
  Graham Herring 
  Zach Cohen                                  020 3934 6630 
 Singer Capital Markets (Nominated Adviser 
  & Joint Broker) 
  Mark Taylor 
  George Tzimas                               020 7496 3000 
 Investec (Joint Broker) 
  Gary Clarence 
  Alex Penney 
                                              020 7597 5970 
  Carlo Spingardi 
  Peel Hunt LLP (Joint Broker) 
  Dr Christopher Golden 
  James Steel                                  020 7418 8900 
 Equity Developments 
  Hannah Crowe 
  Matt Evans            020 7065 2692 

About ECO Animal Health

ECO Animal Health Group plc ("ECO" or "the "GROUP") researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new products.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

March 15, 2022 03:00 ET (07:00 GMT)

Eco Animal Health (LSE:EAH)
Gráfica de Acción Histórica
De Jun 2022 a Jul 2022 Haga Click aquí para más Gráficas Eco Animal Health.
Eco Animal Health (LSE:EAH)
Gráfica de Acción Histórica
De Jul 2021 a Jul 2022 Haga Click aquí para más Gráficas Eco Animal Health.